title: Intestinal pseudo-obstruction associated with oral morphine.
abstract: Morphine is recommended as the strong opioid of choice by the World Health Organization (WHO) for cancer pain management. It is associated with delay in gastro-intestinal transit; as a result, patients may experience marked constipation. We describe a case of intestinal pseudo-obstruction associated with the use of oral morphine in a terminally ill cancer patient.
authors.affiliation: Department of Anaesthesia, Royal Liverpool University Hospital, UK.
authors.forename: B V
authors.initials: BV
authors.lastname: Murthy
authors.forename: F
authors.initials: F
authors.lastname: Ion
authors.forename: J R
authors.initials: JR
authors.lastname: Winstanley
mesh_terms: D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D003248:Constipation / Q000139:chemically induced; D005772:Gastrointestinal Transit / Q000187:drug effects; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects*; D010146:Pain / Q000517:prevention & control; D010166:Palliative Care; D019452:Terminally Ill
chemical_list: D000701:Analgesics, Opioid; D009020:Morphine